Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Agents for the treatment of estrogen-dependent diseases described in a patent

Jan. 24, 2005

Phase I study investigates pralatrexate in NSCLC

Jan. 24, 2005

New data on the pharmacokinetics of 667-Coumate in rats

Jan. 24, 2005

Update on the antitumor effects of bortezomib in MM and non-Hodgkin's lymphoma

Jan. 21, 2005

Not approvable letter for Marqibo

Jan. 21, 2005

AN-152 enters clinical development

Jan. 21, 2005

Teduglutide is a potential anti-mucositis therapeutic for chemotherapy patients

Jan. 21, 2005

GSK prepares and tests novel compounds for proliferative diseases

Jan. 20, 2005

Phase Ib/II trial of Exherin cleared to begin by Swiss Medic

Jan. 20, 2005

Antitumor effects found for MLN-518 in cells expressing different KIT mutations

Jan. 20, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.